Insider buying last 90 days
$601Kin 2 open-market purchases
| Filed | Insider | Type | Value |
|---|---|---|---|
| Nov 12 | FEDERICI WILLIAM J director | Purchase | $274K |
| Nov 10 | MOREL DONALD E JR director | Purchase | $327K |
From Form 4 filings, dated to when each was filed.
Nov 13 close
Stevanato's week centers on the fallout from its Q3 2026 results, reported 3 November, where revenue grew 8% and adjusted EBITDA margin expanded 150 bps to 27.2%, but GLP-1 revenue fell to 17-18% of total revenue and shares dropped roughly 28%. William Blair downgraded the stock to Market Perform from Outperform, citing concerns over the 2027 outlook, persistent Engineering segment issues (down 12% organically), and lower GLP volume growth from a major customer. The sharp decline has also drawn multiple securities fraud investigation announcements from law firms examining whether the company complied with federal securities laws.
Shares closed at $13.73, up 1.2% on the day, but remain well below both the 50-day ($19.67) and 200-day ($17.96) moving averages, with one-month returns at -29.2% and one-year returns at -43.8%. The GekkoIndex reads 79.5, placing the stock in the Buying zone, and the gap to Gekko Fair Value of $20.87 stands at -34.2%.
The next earnings date falls on 3 March 2027, 113 days out and beyond a typical 20-day holding window. No insider, Congress, or unusual options activity appears in the current windows. Seasonality for this point in the calendar shows a -3.7% average move over the next 20 trading days across 5 years, with gains in 2 of those years, a factor worth noting given the stock's typical 20-day move of 7.8%.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Stevanato scores 5 supportive, 1 mixed and 0 headwinds across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
5 supportive1 mixed0 headwinds
Averages disagree
Close $15.80 sits between the 50-day ($19.15) and 200-day ($17.92) averages, or the averages disagree.
See the chart63.8, Accumulation
Reading 63.8 is in the Accumulation zone.
See the GekkoIndex18.0% below
Price is 18% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 90 days: 2 open-market insider purchases.
See smart moneyReports in 108 days
Next report Mar 3, 2027, 108 days away — outside a typical 20-trading-day hold.
See earnings+4.6% on average
From this point in the calendar, the next 20 trading days averaged +4.6% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Stevanato closed at $15.80 on Nov 13, 2026, −33.3% over the past year, inside a 52-week range of $12.05 to $24.01.
Use the left and right arrow keys to read daily values.
Put STVN on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Stevanato develops and produces packaging and delivery equipment used across the pharmaceutical and healthcare fields. Customers rely on it for containment products, drug delivery systems, and medical devices, as well as diagnostic and analytical support, and it has built recognition around this mix of components serving drugmakers and health providers.
Beyond these products, the company builds machinery for jobs like inspecting finished goods visually, assembling parts, packaging output, and shaping glass. It sits within a larger corporate group, operating as a subsidiary of Stevanato Holding S.R.L., while carrying out its manufacturing and engineering work under its own brand.
The company dates back to 1949 and keeps its principal base in Piombino Dese, Italy. Its stock trades on the NYSE under the ticker STVN.
Stevanato’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 63.8, in the Accumulation zone, down 18.5 points over five sessions.
Down 18.5 points over five sessions, from the Buying zone.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 45 | +1.0% | +0.7% | ||
| Accumulation (current zone) | 267 | +0.5% | −0.2% | ||
| Neutral | 363 | −0.8% | −1.4% | ||
| Distribution | 19 | −4.0% | −3.7% | ||
| Selling | 8 | Too few readings yet | |||
Average STVN share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Stevanato trades 18.0% below Gekko Fair Value of $19.27, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Stevanato shares are worth, recalculated every trading day.
$19.27
Gekko Fair Value, Nov 14, 2026
18.0% Undervalued
At the end of Aug 2026 the price was 7.4% below the estimate.
Insiders filed 2 open-market purchases in Stevanato worth $601K, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
$601Kin 2 open-market purchases
| Filed | Insider | Type | Value |
|---|---|---|---|
| Nov 12 | FEDERICI WILLIAM J director | Purchase | $274K |
| Nov 10 | MOREL DONALD E JR director | Purchase | $327K |
From Form 4 filings, dated to when each was filed.
No trades in STVN were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Stevanato reports on Mar 3, 2027, before the open (108 days away), and beat the EPS estimate in 8 of its last 8 reports.
Mar 3, 2027
Expected before the open, 108 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Nov 3, 2026 | $0.18 est $0.18 | $369.4M est $363.3M | −31.9% |
| Aug 4, 2026 | $0.16 est $0.14 | $344.9M est $340.6M | −2.4% |
| May 7, 2026 | $0.13 est $0.12 | $316.1M est $310.5M | −4.1% |
| Mar 4, 2026 | $0.21 est $0.20 | $407.0M est $391.3M | +8.0% |
| Nov 6, 2025 | $0.14 est $0.13 | $355.1M est $385.5M | −3.6% |
| Aug 5, 2025 | $0.11 est $0.10 | $329.7M est $343.2M | −6.0% |
| May 8, 2025 | $0.10 est $0.09 | $281.3M est $301.6M | +10.1% |
| Mar 6, 2025 | $0.19 est $0.18 | $342.3M est $268.2M | +13.1% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Stevanato is $19.46, +23.2% from the last close, from 8 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 8 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 4 | Citi | $20 | +26.6% |
| Nov 4 | UBS | $16 | +1.3% |
| Nov 4 | William Blair | — | — |
| Nov 4 | Bank of America Securities | — | — |
| Nov 3 | KeyBanc | $25 | +58.2% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Stevanato averaged +4.6% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −3.4% | 2 of 5 |
| Next 10 trading days | −0.4% | 3 of 5 |
| Next 15 trading days | −1.1% | 2 of 5 |
| Next 20 trading days | +4.6% | 3 of 5 |
| Next 30 trading days | +1.6% | 2 of 5 |
For scale, STVN’s typical 20-trading-day move in either direction is about 7.9%.
Stevanato’s market cap is $4.32B, with a P/E ratio of 24.3 and revenue of $1.25B over the last twelve months.
2 headlines about Stevanato from the past week, newest first, each linking to the publisher.
Stevanato’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Neutral | 15.0% above |
| ABTAbbott Laboratories | Neutral | 10.5% below |
| DHRDanaher | Neutral | 4.7% above |
| ISRGIntuitive Surgical | Neutral | 17.5% above |
| MDTMedtronic | Neutral | 14.2% below |
| SYKStryker | Neutral | 0.1% below |
A peer links to its own page where one exists.
Stevanato’s market cap is $4.32B at the Nov 13, 2026 close of $15.80, with 49.83M shares outstanding. The shares trade on a P/E ratio of 24.3.
The consensus analyst 12-month price target for Stevanato is $19.46, +23.2% from the last close. Of the 8 firms that rated the stock in the last 90 days, 4 rate it a buy, 4 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Stevanato is undervalued: the Nov 13, 2026 close of $15.80 is 18.0% below Gekko Fair Value of $19.27. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Stevanato is expected to report on Mar 3, 2027, before the market opens (108 days away). Analysts expect earnings of $0.22 per share on revenue of $402.1M. Stevanato beat the earnings estimate in 8 of its last 8 reports, moving 9.9% on average across the report.
Stevanato’s 52-week high is $24.01 and its 52-week low is $12.05; it closed at $15.80 on Nov 13, 2026, −33.3% over the past year. Over the last five years the shares peaked at $36.30 on Aug 9, 2023.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 5 of the 6 items with data read as supportive (gekkoindex, fair value, smart money, earnings risk and seasonality), 1 as mixed (trend). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.